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Abstract
Background: Quorum sensing is a mechanism of  intercellular communication that controls the production of  virulence fac-
tors in Pseudomonas aeruginosa. Inhibition of  quorum sensing can disarm the virulence factors without exerting stress on bacterial 
growth that leads to emergence of  antibiotic resistance.
Objectives: Finding a new quorum sensing inhibitor and determining its inhibitory activities against virulence factors of  Pseu-
domonas aeruginosa PAO1 strain.
Methods:  Quorum sensing was evaluated by estimation of  violacein production by Chromobacterium violaceum CV026.  Molecular 
docking was used to investigate the possible binding of  metformin to LasR and rhlR receptors. The inhibition of  pyocyanin, 
hemolysin, protease, elastase in addition to swimming and twitching motilities, biofilm formation and resistance to oxidative 
stress by metformin was also assessed.
Results: Metformin significantly reduced the production of  violacein pigment. Significant inhibition of  pyocyanin, hemolysin, 
protease and elastase was achieved. Metformin markedly decreased biofilm formation, swimming and twitching motilities and 
increased the sensitivity to oxidative stress. In the molecular docking study, metformin could bind to LasR by hydrogen bonding 
and electrostatic interaction and to rhlR by hydrogen bonding only.
Conclusion: Metformin can act as a quorum sensing inhibitor and virulence inhibiting agent that may be useful in the treatment 
of  Pseudomonas aeruginosa infection.
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Pseudomonas aeruginosa is an opportunistic pathogen that 
affects patients with suppressed immunity. It is the etio-
logic agent of  a number of  nosocomial infections includ-
ing pneumonia, burns, wounds, diabetic foot and urinary 
tract infections1-3.
Antibiotics are considered the first choice in treating 
bacterial infections.  However, the resistance of  bacte-
ria to antibiotics is out pacing the poor supply of  new 
antibiotics. As a result, it is extremely necessary to de-
velop new therapeutic approaches to overcome antibiot-
ic resistance4. One of  these promising approaches is the 
interference with the virulence of  bacteria. This can be 
advantageous due to the importance of  virulence factors 
in pathogenesis. Moreover, targeting virulence makes no 
stress on bacterial growth and can avoid the emergence 
of  resistance5,6.
Quorum sensing is involved in regulation of  virulence 
of  bacteria. Quorum sensing is a type of  intercellular 
signaling in bacteria. This can take place by secretion 
of  signaling molecules or auto-inducers by the bacterial 
cells. These auto-inducers are proportional in their con-
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centration to the bacterial cell number. When reaching a 
critical concentration; the quorum, the activation of  the 
genes encoding virulence factors occurs7. Quorum sens-
ing controls of  the production of  P. aeruginosa virulence 
factors such as elastase, protease, hemolysin, pyocyanin, 
in addition to swimming and twitching motilities, bio-
film formation and resistance to oxidative stress. There 
are three quorum sensing systems in Pseudomonas aerugi-
nosa; the LasI/LasR system, the rhlI/rhlR system and the 
PQS/ MvfR system. The auto-inducer 3-oxodecanoyl 
homoserine lactone (C12 HSL) is produced by LasI and 
binds to the cognate receptor LasR, while rhlI controls 
the production of  the butanoyl homoserine lactone (C4 
HSL) that is recognized by rhlR receptor.  The signal-
ing molecule of  the PQS-MvfR system is 2-heptyl-3-hy-
droxy-4(1H) quinolone (PQS) and its cognate receptor is 
MvfR. PQS-MvfR system functions in regulation of   the 
transcription of  downstream targets8-12.
Metformin is one of  the most commonly prescribed 
oral hypoglycemic for treatment of  type 2 diabetes. It is 
a biguanide drug that is useful especially for obese pa-
tients13,14. Metformin has anti-bacterial activity against 
Pseudomonas aeruginosa15. Moreover, it was found to po-
tentiate the antibacterial activities of  gold nanoparticles 
against superbugs, probably due to the effect on the cell 
wall. Furthermore, it augmented the biofilm eradicating 
activity of  gold nanoparticles16.
This study aimed to investigate the possible anti-quorum 




Luria-Bertani (LB) broth, LB agar and tryptone were ob-
tained from Lab M Limited (Lancashire, United King-
dom).  Mueller Hinton broth, Mueller Hinton agar and 
Tryptone soya broth and Tryptone soya agar were the 
products of  Oxoid (Hampshire, UK). Metformin hydro-
chloride, dimethyl sulphoxide (DMSO), N-hexanoyl ho-
moserine lactone and elastin congo red were purchased 
from Sigma (St. Louis, USA). Other chemicals were of  
pharmaceutical grade.
Bacterial strains
Pseudomonas aeruginosa PAO1 strain was kindly provided 
by the Department of  Microbiology, Faculty of  Pharma-
cy, Mansoura University, while Chromobacterium violaceum 
CV026 was kindly gifted by the Department of  Microbi-
ology, Faculty of  Pharmacy, Ain Shams University.
Determination of  minimum inhibitory concentra-
tion (MIC) and the effect of  sub-inhibitory concen-
tration of  metformin on bacterial growth
The minimum inhibitory concentration of  metformin was 
determined by the broth microdilution method (CLSI)17. 
Two fold serial dilutions of  metformin in Mueller-Hinton 
broth (200, 100, 50, 25, 12.5, 6.25, 3.125, 1.56 mg/ml) 
were added in 100 µl aliquots to the wells of  96-wells mi-
crotiter plate. To each dilution, 100 µl of  PAO1 suspen-
sion in Mueller-Hinton broth with 1 x 106 CFU/ml were 
added. After 20 h of  incubation of  the plate at 37°C, the 
minimum inhibitory concentration was determined as the 
lowest concentration that showed no visible growth.
The effect 1/10 MIC of  metformin on growth of  PAO1 
was determined as modified from Nalca et al.18 LB broth 
was inoculated with overnight culture of  PAO1 in the 
presence and absence of  metformin and overnight in-
cubated at 37 °C. The turbidities of  untreated and met-
formin treated cultures were measured at 600 nm using 
Biotek Spectrofluorimeter (Biotek, USA).
Violacein inhibition assay
The production of  the quorum sensing violacein pigment 
was estimated according to Choo et al.19 Overnight cul-
ture of  Chromobacterium violaceum CV026 was prepared and 
adjusted to an OD600 of  1. After addition of  aliquots of  
100 μl of  LB broth containing N-hexanoyl homoserine 
lactone with and without 1/10 MIC of  metformin to the 
wells of  a 96-well microtiter plate, the bacterial suspen-
sion was added in aliquots of  100 μl. After 16 h of  incu-
bation at 28°C, the plate was completely dried at 60°C. To 
extract violacein, 100 μl of  DMSO was delivered to each 
well followed by incubation at 30°C with shaking. Nega-
tive control using DMSO alone was prepared. Violacein 
was quantified by measuring the absorbance at 590 nm 
using Biotek Spectrofluorimeter (Biotek, USA).
Assay of  biofilm formation and inhibition
For assay of  biofilm inhibition, biofilms were formed in 
the absence and presence of  1/10 MIC of  metformin by 
using the modified method of  Stepanovic et al.20 PAO1 
was grown in TSB and diluted to approximate density of  
1 × 106 CFU/ml. The bacterial suspension (0.1 ml) was 
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added to the wells of  96 well sterile microtiter plate with 
and without 1/10 MIC of  metformin followed by incuba-
tion at 37°C for 24 h. The planktonic cells were discarded 
and the wells were washed 3 times with sterile phosphate 
buffered saline (PBS, pH 7.2).  Methanol (99%) was add-
ed to the wells for 20 minutes as a fixing agent and crystal 
violet (1%) was used to stain the wells for 20 minutes. 
The stain was washed with distilled water, the plate was 
air-dried and 33% glacial acetic acid was used to solubilize 
crystal violet. The absorbance was measured with Biotek 
spectrofluorimeter (Biotek, USA) at 590 nm.
Microscopic analysis of  biofilm inhibition
P. aeruginosa PAO1 was grown overnight in TSB and its 
optical density was adjusted (OD600 = 1). Fresh media 
with sterilized cover slips was inoculated with the adjust-
ed bacterial culture in 50 ml centrifuge tubes with and 
without 1/10 MIC of  metformin. The tubes were incu-
bated at 37°C for 16 h and the cover slips were washed-
with phosphate-buffered saline. The attached biofilms 
were stained with crystal violet (1%) and examined under 
the light microscope using the oil immersion lens (100x 
magnification)21.
Swimming and twitching motilities assay
The effect of  metformin on swimming and twitching 
was detected according to the method of  Rashid and 
Kornberg22 with some modifications. For swimming as-
say, swimming agar plates (tryptone1%, sodium chloride 
0.5% and agar 0.3%) with and without metformin (1/10 
MIC) were prepared. Overnight culture of  PAO1 in tryp-
tone broth was prepared, diluted, and 5µl were stabbed 
into the center of  the agar plates and incubated for 24h at 
37°C. The swimming zones were measured.
In twitching assay, 1% LB agar plates containing met-
formin (1/10 MIC) and control plates were stab-inoculat-
ed with 2µl of  the prepared culture and incubated at 37°C 
for 48h. The agar was removed, the plates were air-dried 
and stained with crystal violet. The dye was removed and 
the plates were washed with water and dried. The twitch-
ing zones were measured.
Protease assay
To estimate the protease inhibiting activity of  metformin, 
the skim milk agar method was used according to Vija-
yaraghavan and Vincent23. P. aeruginosa PAO1 overnight 
cultures in LB broth with and without 1/10 MIC of  met-
formin were prepared. The supernatants were separated 
by centrifugation at 10,000 rpm for 15 min. skim milk 
agar plates (5%) were prepared and supernatants were 
added (100 µl) to the wells made in the skim milk agar 
plates. The plates were incubated overnight at 37°C and 
the clear zones surrounding the wells were measured to 
determine the proteolytic activity in the presence and ab-
sence of  metformin.
Elasatse assay
The elastin congo red assay was used to estimate the 
elastolytic activity of  untreated and metformin treated 
Ps. aeruginosa PAO1 cultures according to Ohman et al.24 
Supernatants were prepared in the same way as in prote-
ase assay and added in amounts of  0.5 ml to tubes with 
elastin congo red reagent [10 mg of  ECR and 0.5 ml of  
buffer composed of  Tris pH 7.2 (0.1 mol/l) and CaCl2 (10 
mol/l)]. After 6 h of  incubation at 37°C with shaking, in-
soluble elastin congo red was discarded by centrifugation 
and the absorbance was measured at 495 nm using Biotek 
Spectrofluorimeter (Biotek, USA).
Pyocyanin assay
The production of  pyocyanin by untreated and met-
formin treated PAO1 was assayed by the method of  Das 
and Manefield25. PAO1 overnight culture in LB broth was 
prepared and diluted to OD600 of  0.4. LB broth (1 ml) 
with and without metformin was inoculated with 10μl of  
the diluted suspension and the cultures were incubated at 
37°C for 48h. To remove the cells and obtain the super-
natants, the tubes were centrifuged at 10,000 rpm for 10 
minutes and the pyocyanin was quantified in the super-
natants by measuring the absorbance at 691nm by Biotek 
Spectrofluorimeter (Biotek, USA).
Sensitivity to oxidative stress
The modified disk assay method of  Hassett et al.26 was 
used to determine the ability of  metformin to inhibit re-
sistance to oxidative stress. Overnight cultures of  PAO1 
in LB were prepared and 0.1 ml aliquots were uniformly 
spread on the surface of  LB agar plates containing 1/10 
MIC of  metformin. Ten μl of  hydrogen peroxide (1.5%) 
was added to sterile paper disks (6 mm) present on the 
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surface of  LB agar plates. Control plates without met-
formin were prepared in the same way. The plates were 
incubated for 24 h at 37°C and the inhibition zones were 
measured.
Docking study
To determine the molecular  interaction of  metformin 
with the LasR, rhlR receptors, docking study was per-
formed. The crystal structure of  P. aeruginosa LasR li-
gand binding domain was obtained from Protein Data 
Bank (PDB ID: 2UV0)27, while the rhlr receptor model 
(ID: P54292.1) was achieved from protein model por-
tal28. The interaction of  metformin, the natural ligand, 
3-oxo-dodecanoylhomoserine lactone and the classical 
quorum sensing inhibitor C30 furanone into the receptor 
active site was investigated using Molegro Virtual Docker 
(MVD Version 6.0). Metformin was drawn into Marvin 
Sketch V5.11.5.29, and, for docking, and the most ener-
getically favored conformer was saved in the file format 
of  (*.mol2). The optimal geometry of  the ligand was de-
termined during the docking process and the E monomer 
was selected for analysis. Water was discarded, cavities 
were determined and the search area was set to be 9 Å 
from the center of  the active site. Iterative simplex algo-
rithm was selected to perform docking process with 10 
runs per ligand, 200 population size, 1000 max iteration 
and 5 poses for each ligand. MolDock docking engine30 
employing docking template and the optimized ligands 
was executed. Finally, the top returned poses were select-
ed for analysis. Similarly, docking metformin and the au-
toinducer, butanoyl homoserine lactone (C4-HSL), into 
the active site of  the rhlr receptor model was performed.
Statistical analysis
Student t tests, Graph Pad Prism 5 was used to investigate 
the significance of  the inhibitory activities of  metformin 
against protease, swimming and twitching motilities, bio-
film formation and eradication, violacein, pyocyanin, 
elastase oxidative stress, and hemolysin. P values <0.05 
were considered statistically significant.
Results
Antibacterial activity of  metformin against Pseudomo-
nas aeruginosa PAO1
Metformin inhibited the growth of Pseudomonas aeruginosa 
PAO1 at 100 mg/ml. The activity of  metformin against 
quorum sensing and virulence was evaluated at 1/10 MIC 
(10 mg/ml).
Growth inhibition assay
The effect of  metformin on QS and virulence may be 
due to the effect on growth of  PAO1. To exclude this 
possibility, the effect of  1/10 MIC of  metformin on 
growth was investigated by measuring the absorbance of  
the bacterial suspensions at 600nm after overnight incu-
bation in LB broth.There was no statistically significant 
difference in the growth rate in the presence or absence 
of  metformin (Fig. 1).
Figure 1.Effect of  metformin on growth of  PAO1. The growth was measured by measuring OD600  after overnight incubation in the absence and presence 
of  1/10 MIC of  metformin. No statistically significant difference was found between the growth rates of  the untreated or treated cultures.
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Biofilm inhibition activities of  metformin
Metformin caused a significant decrease in biofilm for-
mation. It could inhibit biofilm formed by PAO1 strain 
by 67.9% (Fig. 2). To visualize the inhibitory activity of  
metformin on biofilm formation, biofilms were formed 
on glass sterile cover slips in the absence and presence of  
metformin and examined after staining with crystal violet 
under the light microscope. As compared to the control, 
the cells in treated sample show scattered appearance.
Figure 2.Inhibition of  biofilm formation of  PAO1 by 1/10 MIC of  metformin.*, significant P< 0.05.Microscopic visualization of  biofilm under the light 
microscope (X1000) in the treated culture (left) and untreated (right).
Inhibition of  violacein production
Quorum sensing was evaluated quantitatively by measur-
ing the production of  the purple pigment violacein in the 
biosensor strain C. violaceum CV026. This mutant can pro-
duce the pigment only when acylhomoserine lactone is 
added to the growth media. Sub-inhibitory concentration 
of  metformin reduced violacein production in C. violace-
um CV026 by 58.48% (Fig. 3).
Figure 3.Inhibition of  production violacein pigment of  ChhromobacteriumviolaceumCV026 by 1/10 MIC 
of  metformin.*, significant P< 0.05.
Protease inhibition assay
The ability of  metformin to reduce protease production 
by Pseudomonas aeruginosa  PAO1 strain was evaluated by 
measuring the clearance zone surrounding the wells in 
skim milk agar after adding the supernatant of  the treated 
and untreated cultures. Metformin was capable of  reduc-
ing the proteolytic activity by 21.48% (Fig. 4).
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Pyocyanin inhibition assay
Pyocyanin is the green pigment that acts as a redox me-
tabolite in P. aeruginosa. It is cytotoxic to lung tissue during 
infection31. The pyocyanin production in PAO1 was as-
sayed in the absence and presence of  metformin. Met-
formin showed good inhibiting activity against pyocyanin 
production. It reduced its production by 48.67% (Fig 5).
Figure 4.Inhibition of  protease production by 1/10 MIC of  metformin by the skim milk agar method. 
Metformin reduced the diameter of  clear zone around the wells made in skim milk agar. *, significant P< 0.05.
Figure 5.Pyocyanin production in PAO1 untreated (left) and metformin treated (right). The supernatants of  both treated and untreated cultures 
were measured at 691nm. Metformin significantly reduced pyocyanin production. *, significant P< 0.05.
Elastase inhibition assay
The elastolytic activity of  untreated PAO1 culture su-
pernatant in addition to the metformin treated one was 
measured by the investigating ability of  elastase enzyme 
to degrade elastin congo red. The production of  elastase 
in the presence of  metformin was diminished as related 
to the control. The percentage of  inhibition was in the 
range of  23. 26% (Fig. 6).
African Health Sciences Vol 17 Issue 3, September, 2017813
Oxidative stress assay
The tolerance to oxidative stress was evaluated by testing 
the inhibitory effect of  hydrogen peroxide on the growth 
of  PAO1 in the presence and absence of  metformin. 
Metformin could augment the effect of  hydrogen perox-
ide or reduce the tolerance to oxidative stress by 23.15% 
(Fig. 7).
Figure 6.Inhibition of  elastase activity by 1/10 MIC of  metformin. The supernatants of  untreated and metformin treated cultures were incubated 
with elastin congo red. After centrifugation to remove the insoluble dye, the supernatants were measured at 495nm.  Significant decrease in 
elastase activity was found with metformin. *, significant P< 0.05.
Figure 7.Effect of  metformin on resistance to oxidative stress in PAO1.The diameter of  inhibition zone of  
hydrogen peroxide in the presence of  metformin (left) and in absence of  metformin (right).*, significant P< 0.05.
Inhibition of  swimming and twitching motilities
The assay of  the activity of  metformin against swimming 
and twitching motilities was performed and metformin 
was able to inhibit swimming motility by 46.78% (Fig. 8) 
and twitching motility by 55.82% (Fig. 9).
African Health Sciences Vol 17 Issue 3, September, 2017 814
Inhibition of  hemolytic activity
The hemolytic activity of  untreated PAO1 and metformin 
treated culture supernatants was assayed quantitatively 
and the hemoglobin release was measured spectrophoto-
metrically. Metformin could inhibit hemolytic activity of  
PAO1 by 54.27% as compared to the untreated control 
(Fig. 10).
Figure 8.Inhibition of  swimming motility of  PAO1 by 1/10 MIC of  metformin. Metformin decreased swimming (left) as compared to the 
control (right). *, significant P< 0.05.
Figure 9. Inhibition of  twitching motility of  PAO1 by 1/10 MIC of  metformin. Metformin decreased twitching (left) as compared 
to the control (right). *, significant P< 0.05.
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Figure 10. Inhibition of  hemolysin by metformin. Hemoglobin was released by incubation of  culture supernatants with 2% erythrocyte suspension in saline 
for 2h and the absorbance was measured at 540nm. Metformin showed a significant hemolysin inhibiting activity. *, significant P< 0.05.
Docking study
Metformin along with the natural ligand, and the inhibi-
tor C30 furanone were docked into into the active site of  
the quorum sensing protein LasR. Metformin made four 
H-bonds with Asp73, Thr75, Thr115 and Ser129 and 
showed electrostatic interaction with Asp 73 (Fig. 11). 
The C30 furanone a known inhibitor to LasR was found 
to bind through H-bond with Trp60 and Arg 61 while the 
natural ligand makes H-bond with Tyr56, Trp60, Asp73 
and Ser129 (Fig. 12). The MolDock scores for metformin, 
C30 furanone and the natural ligand were -82.37, -80.47 
and -164.49, respectively. The inhibitor lacks the hydro-
phobic side chain that induces the correct formation of  
the hydrophobic core of  LasR and this is the case in met-
formin.
Figure 11.The Molecular docking of  metformin into the active site of  LasR enzyme 3D (Left) and 2D schematic 
view of  the binding (Right).
Figure 12. The Molecular docking of  natural ligand (Top) and C30 furanone (Bottom) into the active site 
of  LasR enzyme 3D (Left) and 2D schematic view of  the binding (Right).
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Also, metformin was docked into rhlr receptor model ac-
tive site. Its interaction to the receptor can be described by 
two H-bond with Cys117 and Asp98, while the auto-in-
ducer C4-HSL makes H-bond with Leu112, Trp108 and 
Arg112 (Fig. 13). These interactions resulted in binding 
energy of  -74.16 and -85.24 for metformin and C4-HSL 
respectively. The hydrophobic acyl group of  C4-HSL is 
important factor for the conformational change to be an 
inducer that is absent in metformin which make it a pos-
sible inhibitor.
Figure 13. The Molecular docking of  C4-HSL (Top) and metformin (Bottom) into the active site of  rhlr 
receptor model 3D (Left) and 2D schematic view of  the binding (Right).
Discussion
Quorum sensing represents a highly valuable target for 
modern anti-virulence approach that tends to bypass the 
problem of  emergence of  antibiotic resistance. This is 
because of  its role in regulation of  virulence factors pro-
duction together with biofilm formation and bacterial 
motility32.
Inhibition of  QS is usually investigated via the competi-
tive inhibition of  auto-inducers binding to their cognate 
receptors. However, most investigated quorum sensing 
inhibitors were toxic and cannot be used clinically33. To 
solve this problem, screening of  FDA approved drugs 
for possible quorum sensing inhibition may be a useful 
alternative option that enables their clinical application 
for treatment of  infections. This approach was found to 
be successful in our previous study on glyceryl trinitrate34.
In the present study, the oral hypoglycemic drug met-
formin was tested for its potential quorum sensing inhi-
bition. Metformin could inhibit PAO1 growth at 100 mg/
ml. metformin (1/10 MIC) that showed no effect on bac-
terial viability was used to detect the effect of  metformin 
against quorum sensing and virulence of  PAO1.
Chromobacterium violaceum CV026 was used as a biosensor 
of  quorum sensing. This mutant can produce the purple 
violacein pigment only when acylhomoserine lactones are 
added to the growth media. This pigment is produced un-
der the control of  CVi/R QS system35. Quantitative assay 
of  violacein production was performed in the presence 
and absence of  sub-inhibitory concentration of  met-
formin, and it was found that metformin could reduce 
the pigment production. Furthermore, the possible inter-
action of  metformin with LasR and rhlR receptors was 
investigated by molecular docking. Metformin could bind 
with LasR via hydrogen bonding and electrostatic attrac-
tion. The docking score of  metformin was slightly lower 
than C30 furanone, so its binding ability is more or less 
similar to that of  C30 furanone. Considering the interac-
tion with rhlR receptor, the docking scores of  metformin 
and the natural ligand butanoyl homoserine latone indi-
cate comparable abilities of  binding to rhlR. These results 
indicate that metformin is a quorum sensing inhibitor in 
PAO1.
The study was then expanded to investigate the activity 
of  metformin against quorum sensing regulated virulence 
factors. Metformin significantly decreased the production 
of  pyocyanin. Pyocyanin is responsible for production of  
reactive oxygen species by oxidation of  reduced glutathi-
one in the cell with concomitant reduction of  oxygen32.
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Biofilm formation and development is affected by quo-
rum sensing36. Metformin, at sub-inhibitory concentra-
tion, showed a good biofilm inhibiting activity.
Quorum sensing is involved in resistance of  PAO1 to ox-
idative stress due to interference with phagocytosis and 
intracellular killing by reactive oxygen species in neutro-
phils and the production of  catalase and superoxide dis-
mutase37,38. Metformin could increase the sensitivity of  
PAO1 to hydrogen peroxide.
Motility is linked to bacterial adhesion and subsequent 
biofilm formation.  QS LasI/R and rhlI/R regulate bac-
terial motility39. Moreover, QS-deficient strains with im-
paired motilities can form thin and disperse biofilms40. 
Metformin could reduce both swimming and twitching 
motilities of  PAO1.
In this study, metformin inhibited hemolysin, elastase and 
protease to different extents. The anti-hemolytic activity 
was higher. Pseudomonas aeruginosa produces these hydro-
lytic enzymes to enable the spread of  bacteria inside the 
host tissues and resistance to the host immunity41.
Conclusion 
Metformin is a novel quorum sensing inhibitor in PAO1 
that has the merit of  being FDA approved for human 
use. It can be used as anti-virulence agent in the treatment 
of  P. aeruginosa infection.
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